Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Bashar Saad
 -- 2632 2022-11-11 07:04:51 |
2 update references and layout
Amina Yu
 + 1 word(s) 2633 2022-11-11 08:42:31 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Saad, B. Medicinal Plants with Immunomodulatory Properties. Encyclopedia. Available online: https://encyclopedia.pub/entry/34110 (accessed on 27 July 2024).
Saad B. Medicinal Plants with Immunomodulatory Properties. Encyclopedia. Available at: https://encyclopedia.pub/entry/34110. Accessed July 27, 2024.
Saad, Bashar. "Medicinal Plants with Immunomodulatory Properties" Encyclopedia, https://encyclopedia.pub/entry/34110 (accessed July 27, 2024).
Saad, B. (2022, November 11). Medicinal Plants with Immunomodulatory Properties. In Encyclopedia. https://encyclopedia.pub/entry/34110
Saad, Bashar. "Medicinal Plants with Immunomodulatory Properties." Encyclopedia. Web. 11 November, 2022.
Medicinal Plants with Immunomodulatory Properties
Edit
This entry is adapted from the peer-reviewed paper 10.3390/immuno2040038

Numerous scientific papers published highlight the immunological role of adipocytes and their role in inflammatory responses through the secretion of adipocytokines (adipokines), which regulate the adipocyte phenotype through complex mechanisms of action. Normally, adipose tissue produces anti-inflammatory mediators, but with increasing cell hypertrophy, adipose tissue secretes a number of pro-inflammatory cytokines and hormones, such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), plasminogen activator inhibitor-1 (PAI-1), angiotensinogen, transforming growth factor-β (TGF-β), leptin, adiponectin, resistin, and monocyte chemoattractant protein-1 (MCP-1). They also produce the pro-inflammatory hormone leptin, which inhibits the secretion of the anti-inflammatory hormone adiponectin. Compared with subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) has a higher rate of lipolysis, a higher infiltration rate of macrophages, and a higher secretion of IL -6, MCP-1, and other inflammation-related markers. With increasing obesity, monocytes infiltrate into adipose tissues, where they mature into macrophages.

obesity inflammation medicinal plants

1. Curcuma Longa Rhizomes (Turmeric)

Curcuma longa rhizomes (Turmeric) have a long history of use as a health-promoting agent [1][2][3][4][5][6][7]. The roots of turmeric have been known for their health values for hundreds of years in Ayurveda, Chinese, and Greco-Arab and Islamic medicine [8][9]. Over 800 scientific reports and more than 100 clinical trials have investigated the cellular, molecular, and pharmacological effects of curcumin. Many of these reports emphasize the potential benefits of curcumin in the treatment of chronic diseases such as cardiovascular disease, T2D, overweight/obesity, cancer, autoimmune diseases, neurological and mental disorders [4][10][11][12][13]. Most published reports have linked the benefits of turmeric to its antioxidant and anti-inflammatory properties [14].
Curcumin, the major polyphenol from turmeric, has been reported to promote weight loss and reduce the incidence of obesity-related diseases [12][13][15]. Curcumin intake reduces levels of TNF-α and IL-6 and increases the level of adiponectin in the plasma of obese and overweight individuals. In addition, curcumin regulates a number of biochemical and molecular targets, including transcription factors (NF-kB, NLP3), signaling pathways, and other complex regulatory systems, resulting in attenuation of the chronic low-grade inflammatory response in adipose tissue.
Several clinical studies have shown that the interaction of curcumin with transcription factors, cellular receptors, growth factors, enzymes, cytokines, and chemokines reduces inflammation in obese individuals by restoring the balance between pro-inflammatory and anti-inflammatory mediators [16][17]. Several published studies clearly indicate that curcumin significantly decreases pro-inflammatory cytokine levels and increases plasma adiponectin levels in obese and overweight individuals. Furthermore, curcumin can affect multiple molecular targets, including transcription factors (NF-kB, NLP3), signaling pathways, and other complex regulatory systems in adipose tissue, resulting in the attenuation of chronic low-grade inflammatory response. In addition, there are some reports suggesting that curcumin enhances the effect of diet and lifestyle intervention in overweight/obese people with metabolic syndrome [18][19]. However, the poor bioavailability of curcumin poses a problem for its use. To increase the bioavailability of curcumin, various delivery systems, such as micelles, liposomes, phospholipid complexes, nanostructured lipid carriers, and biopolymer nanoparticles have been developed [12][13][15][20][21][22][23]. The future of curcumin as an approved option for the prevention or treatment of obesity and its associated low-grade inflammation and other complications depends on the results of high-quality and large cohort studies in the future. However, based on current knowledge, curcumin has a good safety profile and is well tolerated. This low toxicity may be due to the low bioavailability, therefore, an increase of biodisponibility must be carried out cautiously.

2. Camellia sinensis (Tea Leaves)

Camellia sinensis (Tea leaves) are the source of white, green, and black tea. Several observational clinical trials have shown that the consumption of tea or green tea has a beneficial effect against obesity. The effects observed in these studies are low, so statistical confirmation is especially difficult in rather healthy people. For example, a cross-sectional study of 1210 adults showed that regular tea drinkers for more than 10 years showed a 19.6% reduction in body fat percentage and a 2.1% reduction in waist-to-hip ratios when compared with irregular tea drinkers [24]. Recent results from a clinical trial of 6472 adults showed that tea consumers had a lower average waist circumference and body mass index (BMI) than non-consumers [25]. However, a more recent study of 3539 participants showed that green tea was not associated with visceral obesity or metabolic syndrome [26]. Therefore, further studies are needed to clarify the anti-obesity properties of green tea.
Epigallocatechin-3-gallate (EGCG), derived from green tea, and theaflavins, derived from black tea, are the best-studied active compounds from tea. EGCG, the main polyphenolic compound in green tea, has a number of health-promoting effects. These include anti-inflammatory, antioxidant, anti-obesity, anti-cancer, and anti-diabetic properties. The anti-inflammatory effects of EGCG, such as attenuating the secretion of resistin from adipocytes, are exerted through the ERK-dependent pathway. EGCG-enhanced production of adiponectin is mediated, at least in part, by inhibition of the protein Krueppel-like factor 7 (KLF7), which downregulates the expression of genes controlling adipogenesis [4][27][28][29][30][31][32][33][34][35]. EGCG also reduced inflammation and oxidative stress associated with aging in high-fat diet-induced rats. EGCG significantly reduced systemic levels of IL-6, tumor necrosis factor-α (TNF)-α, ROS, and superoxide dismutase (SOD). EGCG also increased the expression of sirtuin-1 (SIRT1), catalase, fatty acid-binding protein-1, glutathione S-transferase (GST)-A2, and acyl-CoA synthetase-1, but significantly decreased the expression of nuclear factor (NF)-κB, ACC -1, and FASN in the liver [36].

3. Capsaicin

A fat-soluble alkaloid, extracted from Capsicum (hot pepper) fruits is the major bioactive compound in red chili peppers. It is a pungent molecule that affects thermoregulation, triggers autonomic reflexes, and is well absorbed [37]. Capsaicin is in the pipeline for phase III clinical trials as a treatment option for rheumatoid arthritis, postoperative pain, and chronic neuropathic and musculoskeletal pain [37]. In recent decades, the pharmacological benefits of capsaicin and its underlying mechanisms have been extensively studied. The main beneficial medicinal properties of capsaicin include analgesic, antioxidant, anti-inflammatory, anti-cancer, anti-obesity, cardio-protective, and metabolic modulatory effects [38][39][40][41]. Capsaicin binds to Transient Receptor Potential Channel Vanilloid type-1 (TRPV1) [42][43], a transmembrane ion channel [44]. TRPV1 is expressed in many cell types and tissues, including nerve fibers, trigeminal ganglia, testis, adipocytes, smooth muscle cells, endothelial cells, pancreatic β-cells, liver, heart, skeletal muscle, and kidneys [45]. Selective silencing of TRPV1 by specific RNA interference reduced the effect of capsaicin on calcium influx and inhibition of adipogenesis in 3T3-L1 adipocytes [46].
Several metabolic studies have shown that capsaicin is a potent anti-inflammatory substance [47][48][49] that could attenuate metabolic inflammatory conditions such as obesity, T2DM, osteoarthritis, and non-alcoholic fatty liver disease. Capsaicin has been shown to attenuate (via blocking NF-κB, which is likely mediated by PPARγ activation) the expression and secretion of MCP-1 and IL -6 from adipose tissue of mice and to increase the production of adiponectin. It has also been shown that capsaicin administration in vivo improves obesity-induced insulin resistance [4][38][39][40][41]. Moreover, in healthy rats, capsaicin decreased oxidative stress measured by malondialdehyde and diene conjugation in tissues [50]. Capsaicin prevented lipid peroxidation and carbonyl formation in proteins in human erythrocytes subjected to oxidative stress [51].

4. Zingiber Officinale (Ginger)

An herbaceous perennial plant of the family Zingiberaceae, it is one of the most famous medicinal herbs in traditional Greco-Arab and Islamic medicine, Ayurveda, and Chinese medicine for centuries. It is reported to have several health-promoting properties. These include antiulcer, anti-inflammatory, antioxidant, antiplatelet, anti-diabetes, anti-obesity, anti-hyperlipidemia, as well as cardiovascular and anti-cancer activities. The anti-obesity activities of ginger are most likely due to the highly significant inhibitory action of ginger on the absorption of dietary fats by reducing pancreatic lipase activity. Ginger contains active compounds such as gingerol, paradol, and 6-shogaol responsible for the anti-inflammatory effects of ginger. 6-shogaol elevates adiponectin production and inhibits the TNF-α-induced downregulation of adiponectin production in adipocytes, most likely by upregulating PPARγ activity. As for 6-shogaol, 6-gingerol inhibits TNF-α-mediated inhibition of adiponectin in adipocytes; however, the pathways of their inhibitory effects are different; 6-gingerol inhibits JNK signaling pathways in TNF-α-induced adipocytes without affecting PPARγ transactivation, whereas the anti-inflammatory effects of 6-shogaol is PPARγ-dependent [52][53][54][55].
Systematic review and meta-analysis of 16 randomized controlled trials RCTs comprising 1010 participants provide convincing evidence for a significant effect of ginger in lowering circulating C-reactive protein (CRP), high sensitivity C-reactive protein (hs-CRP), and TNF-α levels. Large-scale RCTs are still needed to draw concrete conclusions about the effect of ginger on other inflammatory mediators [56].

5. Nigella sativa (Black Seeds)

Nigella sativa (Black seeds), also called black cumin or black seed, is famous for its culinary uses and was historically valuable in traditional Greco-Arab and Islamic medicine and other traditional medicines. Prophet Muhammad (PBUH) (570–632 AD) said, “Black seed can cure any disease except death.” Avicenna (980–1037 AD) mentioned black seed in his canon of medicine as “the seed that stimulates the energy of the body and promotes recovery from fatigue and dejection” [52][53][57][58][59]. Numerous scientific papers have been published addressing the safety and efficacy of black seed and thymoquinone (the main active ingredient). A “Medline” and “Google Scholar” search with “black seed”/“Nigella sativa” or “thymoquinone” yields more than 1100 publications.
Nigella sativa exhibits pleiotropic pharmacological activity and a wide range of health-promoting effects. Both the seeds and their major bioactive constituent thymoquinone have been found to exert significant antioxidant, anti-inflammatory, immune enhancing, cell survival improving, and energy metabolism promoting effects underlying various health benefits. These include protection against metabolic, cardiovascular, digestive, hepatic, renal, respiratory, reproductive, and neurological diseases, T2DM, obesity, hypotension, allergies, antimicrobial effects, and cancer [3][60]. Despite significant advances in pharmacological benefits, these black seeds and their active compounds are still far from the clinical application [61].
Black seed and thymoquinone attenuate the obesity-related low-grade inflammation through activation of natural killer cells proliferation and differentiation, monocyte activities, T-cell based immunity, as well as stimulation macrophage activity. For example, black seed significantly attenuates nitric oxide production and serum levels of pro-inflammatory cytokines and mediators, including IL-4, IL-5, IL-6, IgE, IgG1, and OVA-specific IgG1 ovalbumin-treated rats. Rats treated with black seed experienced a reduced T-cell response and attenuated T-cell proliferation in the spleen without histopathological changes in lung tissue. Control, untreated rats exhibited a thickening of the alveolar wall and increased numbers of goblet cells. These data suggest that black seed inhibits Th-2-induced T-cell proliferation and differentiation, thereby halting the inflammatory response [62][63][64]. Pretreatment with thymoquinone attenuated Th-2-cell mediated lung inflammation, lung eosinophilia, and goblet cell hyperplasia. Furthermore, thymoquinone downregulated COX-2 expression, PGD2 production, and a slight inhibition in COX-1 expression and PGE2 production in rats. COX-2 mediates the inducible inflammatory response by converting arachidonic acid to prostaglandins (a pro-inflammatory cytokine), whereas COX-1 mediates constitutive or “housekeeping” inflammation. Long-term elevated COX-2 activity is recognized as an underlying cause of many chronic inflammatory disorders, thus, inhibition of COX-2 is favorable in cases of chronic inflammatory conditions. Black seeds and thymoquinone exert their anti-inflammatory effects primarily via downregulation of COX-2 and PGD2 production [57][58][59].
Nigella sativa oil reduced the levels of IL-6 and IL-1β in human pre-adipocytes [62]. Treatment with Nigella sativa oil (400 mg/kg) in rats with carrageenan-induced paw edema, improved the pro-inflammatory cytokines IL-6, IL-12, and TNF-α in paw exudates and sera [63][64]. Furthermore, topical application of balm stick containing 10% Nigella sativa oil in rats with paw edema markedly alleviated acute and sub-acute inflammation with a significant edema reduction, with a 43% lower leucocytes count and 50% lower TNF-α level compared to control on the inflammation area [65].
Overall, the evidence supports the anti-inflammatory potentials of black seeds and thymoquinone, however, most of the studies so far have been conducted in animal models. Future clinical trials should focus on determining the anti-inflammatory potential in ameliorating human diseases

6. Punica granatum (Pomegranate)

Punica granatum (pomegranate) has long been used in major traditional medicine systems to promote health and treat many diseases. In recent decades, a large number of scientific papers have been published on the health-promoting effects of pomegranate. These include antioxidant, anti-inflammatory, cardiovascular, anti-obesity, anti-diabetic, and anti-cancer effects.
Pomegranate fruits and other aerial parts of the plant contain several bioactive molecules. These include phenolic acids, hydrolyzable tannins, condensed tannins, and flavonoids, as well as other types of bioactive constituents responsible for the observed antimicrobial, anti-cancer, antioxidant, and anti-inflammatory activities. Pomegranate-derived punicalagin isomer, ellagic acid, and anthocyanins are known for their antioxidant properties and reduction of lipid oxidation. Pomegranate extracts and juice are also effective in stimulating vascular endothelial NO synthase and plasma NO levels, suggesting clinical application in metabolic syndrome [3][52][53][60][66].
As mentioned earlier, obesity is associated with elevated levels of adipocyte-derived pro-inflammatory cytokines such as TNF-a and IL-6, which affect metabolism in several ways. Pomegranate affects adipocyte-specific gene expression, triacylglycerol release, lipoprotein lipase downregulation, and insulin sensitivity [66][67][68][69]. Pomegranate active compounds have been shown to reduce the secretion of IL-6, thereby reducing the complications associated with obesity. Thus, in vitro experiments reported that pomegranate seed oil (PSO) decreased the activities of cyclooxygenase and lipoxygenase. The activity of cyclooxygenase, a key enzyme in the conversion of arachidonic acid to prostaglandins (important mediators of inflammation), was reduced to 60% by PSO. Lipoxygenase, which catalyzes the conversion of arachidonic acid to leukotrienes, also important mediators of inflammation, was inhibited by PSO by 75% compared to controls [66]. The effects of pomegranate extract consumption on plasma inflammation, oxidative stress biomarkers, and serum metabolic profiles were investigated in a randomized, double-blind, placebo-controlled clinical trial in overweight and obese subjects. Herein, 48 overweight and obese participants were randomized to receive either 1 g of pomegranate extract or placebo, daily for 30 days. Ingestion of pomegranate extract resulted in significant reductions in mean serum levels of glucose, insulin, total cholesterol, LDL-C, plasma malondialdehyde (biomarker of oxidative stress), and IL-6. These results suggest that the consumption of pomegranate extract may reduce the complications associated with obesity [65][66][67][68][69].
A systematic review of 20 clinical trials suggests that pomegranate and its active ingredients lower BMI, hypertension, blood glucose levels, triglycerides, total cholesterol, and LDL. It may also increase HDL levels and improve insulin resistance. Although relevant effects have been observed, further well-designed clinical studies are needed to determine the proper formulations and dosages that can be used to prevent or treat metabolic syndrome components [70].
Regarding the anti-inflammatory effects of pomegranate, a recent review article considered 16 randomized controlled trials (RCTs) involving 572 subjects [71]. Pomegranate intake significantly lowered levels of hs-CRP, IL-6, and TNF-α compared with placebo. No significant reduction was observed in CRP, E-selectin, ICAM, VCAM, or MDA compared to placebo [71].

7. Grapes, Peanuts, and Many Berries

Grapes, peanuts, and many berries contain resveratrol, a nonflavonoid that belongs to the stilbene group. Resveratrol is a promising phytochemical that can be easily incorporated into the diet to combat adipose tissue inflammation and other obesity-related metabolic diseases. There are several lines of evidence that resveratrol has antiadipogenic effects. In vitro studies show that resveratrol stimulates apoptosis in mature adipocytes and targets triacylglycerol metabolism at white adipose tissue (WAT). These effects appear to be mediated by the attenuation of fatty acid uptake and lipogenesis in adipose tissue. In addition, the increase in brown adipose tissue (BAT) thermogenesis and associated energy depletion may help explain the body fat-lowering effects of resveratrol. However, a meta-analysis of 19 clinical trials found that only three studies showed any type of beneficial effect. The meta-analysis found no significant effect on weight or BMI. A small effect was found on waist circumference [72].
Resveratrol is a potent anti-inflammatory phytochemical that attenuates the activity of NF-κB and ERK. In mouse adipose tissue, resveratrol attenuated the production of TNF-α, interferon α, and (IFNα and IFNβ), and IL -6 and their upstream signaling molecules, including TLR 2/4 triggered by a high-fat diet, Toll IL-1 receptor (TIR) domain-containing adaptor protein (TIRAP), TIR domain-containing adapter-inducing interferon (TRIF), TNF receptor-associated factor 6 (TRAF6), interferon regulatory factor 5 (IRF5), p-IRF3, and NF-κB. In addition, improvement of insulin sensitivity and attenuation of inflammation by resveratrol are mediated via inhibition of adipokine production (e.g., resistin and retinol-binding protein 4), attenuation of oxidative stress, and stimulation of Akt-mediated insulin signaling [4][54][73][74][75].
A systematic review of 17 RCTs involving 736 subjects found significant reductions in TNF-α and hs-CRP levels after resveratrol supplementation. Resveratrol supplementation had no significant effect on the levels of IL-6. Statistically, significant heterogeneity was observed in relation to the type of sample IL-6 and study duration for the inflammatory markers IL-6, TNF-α, and hs-CRP [76].

References

  1. Saad, B. Integrating traditional Greco-Arab and Islamic herbal medicine in research and clinical practice. In Phytotherapies: Safety, Efficacy, and Regulation; Ramazan, I., Ed.; Wiley-Blackwell John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2015; pp. 142–177.
  2. Saad, B.; Zaid, H.; Said, O. Tradition and Perspectives of Diabetes Treatment in Greco-Arab and Islamic Medicine. In Bioactive Food as Dietary Interventions for Diabetes; Watson, R.R., Preedy, V.R., Eds.; Academic Press: San Diego, CA, USA, 2013; pp. 319–326.
  3. Saad, B.; Said, O. Herbal Medicine. In Greco-Arab and Islamic Herbal Medicine: Traditional System, Ethics, Safety, Efficacy and Regulatory Issues; Wiley-Blackwell John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2011; pp. 47–71.
  4. Saad, B.; Zaid, H.; Shanak, S.; Kadan, S. Prevention and treatment of obesity-related diseases by diet and medicinal plants. In Anti-Diabetes and Anti-Obesity Medicinal Plants and Phytochemicals Safety, Efficacy, and Action Mechanisms; Springer: Berlin/Heidelberg, Germany, 2017; pp. 95–141.
  5. Yang, C.S.; Zhang, J.; Zhang, L.; Huang, J.; Wang, Y. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol. Nutr. Food Res. 2016, 60, 160–174.
  6. Saad, B.; Azaizeh, H.; Said, O. Tradition and perspectives of Arab herbal medicine: A Review. eCAM 2005, 2, 475–479.
  7. Finicelli, M.; Di Salle, A.; Galderisi, U.; Peluso, G. The Mediterranean Diet: An Update of the Clinical Trials. Nutrients 2022, 14, 295.
  8. Varì, R.; Scazzocchio, B.; Silenzi, A.; Giovannini, C.; Masella, R. Obesity-Associated Inflammation: Does Curcumin Exert a Beneficial Role? Nutrients 2021, 13, 1021.
  9. Kocaadam, B.; Sanlier, N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit. Rev. Food Sci. Nutr. 2017, 57, 2889–2895.
  10. Murata, M. Inflammation and cancer. Environ. Health Prev. Med. 2018, 23, 50.
  11. Ďuračková, Z. Some Current Insights into Oxidative Stress. Physiol. Res. 2010, 59, 459–469.
  12. Ishibashi, T. Molecular Hydrogen: New Antioxidant and Anti-inflammatory Therapy for Rheumatoid Arthritis and Related Diseases. Curr. Pharm. Des. 2013, 19, 6375–6381.
  13. Debnath, T.; Kim da, H.; Lim, B.O. Natural products as a source of anti-inflammatory agents associated with in-flammatory bowel disease. Molecules 2013, 18, 7253–7270.
  14. Ferguson, J.J.A.; Abbott, K.A.; Garg, M.L. Anti-inflammatory effects of oral supplementation with curcumin: A systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. 2020, 79, 1043–1066.
  15. Malhotra, A.; Nair, P.; Dhawan, D.K. Premature Mitochondrial Senescence and Related Ultrastructural Changes during Lung Carcinogenesis Modulation by Curcumin and Resveratrol. Ultrastruct. Pathol. 2012, 36, 179–184.
  16. Shehzad, A.; Ha, T.; Subhan, F.; Lee, Y.S. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur. J. Nutr. 2011, 50, 151–161.
  17. Shimizu, K.; Funamoto, M.; Sunagawa, Y.; Shimizu, S.; Katanasaka, Y.; Miyazaki, Y.; Wada, H.; Hasegawa, K.; Morimoto, T. Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases. Eur. Cardiol. Rev. 2019, 14, 117–122.
  18. Di Pierro, F.; Bressan, A.; Ranaldi, D.; Rapacioli, G.; Giacomelli, L.; Bertuccioli, A. Potential role of bioavailable curcumin in weight loss and omental adipose tissue decrease: Preliminary data of a randomized, controlled trial in overweight people with metabolic syndrome. Preliminary study. Eur. Rev. Med. Pharmacol. Sci. 2015, 19, 4195–4202.
  19. Akbari, M.; Lankarani, K.B.; Tabrizi, R.; Ghayour-Mobarhan, M.; Peymani, P.; Ferns, G.; Ghaderi, A.; Asemi, Z. The effects of curcumin on weight loss among patients with metabolic syndrome and related disorders: A systematic review and me-ta-analysis of randomized controlled trials. Front. Pharmacol. 2019, 10, 649.
  20. He, Y.; Yue, Y.; Zheng, X.; Zhang, K.; Chen, S.; Du, Z. Curcumin, Inflammation, and Chronic Diseases: How Are They Linked? Molecules 2015, 20, 9183–9213.
  21. Srinivasan, K. Black Pepper and its Pungent Principle-Piperine: A Review of Diverse Physiological Effects. Crit. Rev. Food Sci. Nutr. 2007, 47, 735–748.
  22. Mantzorou, M.; Pavlidou, E.; Vasios, G.; Tsagalioti, E.; Giaginis, C. Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data. Phytother. Res. 2018, 32, 957–975.
  23. Kumar, A.; Harsha, C.; Parama, D.; Girisa, S.; Daimary, U.D.; Mao, X.; Kunnumakkara, A.B. Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases. Phytother. Res. 2021, 35, 6768–6801.
  24. Wu, C.-H.; Lu, F.-H.; Chang, C.-S.; Chang, T.-C.; Wang, R.-H.; Chang, C.-J. Relationship among Habitual Tea Consumption, Percent Body Fat, and Body Fat Distribution. Obes. Res. 2003, 11, 1088–1095.
  25. Tanabe, H.; Pervin, M.; Goto, S.; Isemura, M.; Nakamura, Y. Beneficial Effects of Plant Polyphenols on Obesity. Obes. Control Ther. 2017, 4, 1–16.
  26. Koyama, T.; Maekawa, M.; Ozaki, E.; Kuriyama, N.; Uehara, R. Daily Consumption of Coffee and Eating Bread at Breakfast Time Is Associated with Lower Visceral Adipose Tissue and with Lower Prevalence of Both Visceral Obesity and Metabolic Syndrome in Japanese Populations: A Cross-Sectional Study. Nutrients 2020, 12, 3090.
  27. Brown, A.L.; Lane, J.; Holyoak, C.; Nicol, B.; Mayes, A.E.; Dadd, T. Health effects of green tea catechins in over-weight and obese men: A randomised controlled cross-over trial. Br. J. Nutr. 2011, 106, 1880–1889.
  28. Zheng, J.; Yang, B.; Huang, T.; Yu, Y.; Yang, J.; Li, D. Green tea and black tea consumption and prostate cancer risk: An exploratory meta-analysis of observational studies. Nutr. Cancer J. 2011, 63, 663–672.
  29. Sun, C.L.; Yuan, J.M.; Lee, M.J.; Yang, C.S.; Gao, Y.T.; Ross, R.K.; Yu, M.C. Urinary tea polyphenols in relation to gastric and esophageal cancers: A prospective study of men in Shanghai, China. Carcinog. J. 2002, 23, 1497–1503.
  30. Ahmad, N.; Fayes, D.K.; Nieminen, A.L.; Agarwal, R.; Mukhtar, H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 1997, 89, 1881–1889.
  31. Bettuzzi, S.; Brausi, M.; Rizzi, F.; Castagnetti, G.; Peracchia, G.; Corti, A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. J. Cancer Res. 2006, 66, 1234–1240.
  32. Kao, Y.H.; Hiipakka, R.A.; Liao, S. Modulation of obesity by a green tea catechin. Am. J. Clin. Nutr. 2000, 72, 1232–1234.
  33. Kao, Y.H.; Hiipakka, R.A.; Liao, S. Modulation of endocrine systems and food intake by green tea epigallocat-echingallate. Endocrinol. J. 2000, 141, 980–987.
  34. Dulloo, A.G.; Seydoux, J.; Girardier, L.; Chantre, P.; Vandermander, J. Green tea and thermogenesis: Interactions between catechin-polyphenols, caffeine and sympathetic activity. Int. J. Obes. 2000, 24, 252–258.
  35. Kakuda, T.; Nozawa, A.; Unno, T.; Okamura, N.; Okai, O. Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Biosci. Biotechnol. Biochem. 2000, 64, 287–293.
  36. Yuan, H.; Li, Y.; Ling, F.; Guan, Y.; Zhang, D.; Zhu, Q.; Liu, J.; Wu, Y.; Niu, Y. The phytochemical epigallocatechin gallate prolongs the lifespan by improving lipid metabolism, reducing inflammation and oxidative stress in high-fat diet-fed obese rats. Aging Cell 2020, 19, e13199.
  37. Patowary, P.; Pathak, M.P.; Zaman, K.; Raju, P.; Chattopadhyay, P. Research progress of capsaicin responses to various pharmacological challenges. Biomed. Pharmacother. 2017, 96, 1501–1512.
  38. Surh, Y.J. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: A short review. Food Chem. Toxicol. 2002, 40, 1091–1097.
  39. Kang, J.-H.; Kim, C.-S.; Han, I.-S.; Kawada, T.; Yu, R. Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett. 2007, 581, 4389–4396.
  40. Woo, H.M.; Kang, J.H.; Kawada, T.; Yoo, H.; Sung, M.K.; Yu, R. Active spice-derived components can inhibit inflam-matory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci. 2007, 80, 926–931.
  41. Kim, C.S.; Kawada, T.; Kim, B.S.; Han, I.S.; Choe, S.Y.; Kurata, T.; Yu, R. Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell. Signal. 2003, 15, 299–306.
  42. Zeyda, M.; Stulnig, T.M. Adipose tissue macrophages. Immunol. Lett. 2007, 112, 61–67.
  43. Hotamisligil, G.S. Inflammation and metabolic disorders. J. Nat. 2006, 444, 860–867.
  44. Liao, M.; Cao, E.; Julius, D.; Cheng, Y. Structure of the TRPV1 ion channel determined by electron cryo-microscopy. Nature 2013, 504, 107–112.
  45. Panchal, S.K.; Bliss, E.; Brown, L. Capsaicin in Metabolic Syndrome. Nutrients 2018, 10, 630.
  46. Zhang, L.L.; Yan Liu, D.; Ma, L.Q.; Luo, Z.D.; Cao, T.B.; Zhong, J.; Yan, Z.C.; Wang, L.J.; Zhao, Z.G.; Zhu, S.J.; et al. Acti-vation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ. Res. 2007, 100, 1063–1070.
  47. Kang, J.H.; Tsuyoshi, G.; Han, I.S.; Kawada, T.; Kim, Y.M.; Yu, R. Dietary capsaicin reduces obesity-induced insulin re-sistance and hepatic steatosis in obese mice fed a high-fat diet. Obesity 2010, 18, 780–787.
  48. Song, J.-X.; Ren, H.; Gao, Y.-F.; Lee, C.-Y.; Li, S.-F.; Zhang, F.; Li, L.; Chen, H. Dietary Capsaicin Improves Glucose Homeostasis and Alters the Gut Microbiota in Obese Diabetic ob/ob Mice. Front. Physiol. 2017, 8, 602.
  49. Li, Q.; Li, L.; Wang, F.; Chen, J.; Zhao, Y.; Wang, P.; Nilius, B.; Liu, D.; Zhu, Z. Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor delta activation. Pflugers Arch. 2013, 465, 1303–1316.
  50. Lee, C.Y.; Kim, M.; Yoon, S.W.; Lee, C.H. Short-term control of capsaicin on blood and oxidative stress of rats in vivo. Phytother. Res. 2003, 17, 454–458.
  51. Luqman, S.; Rizvi Syed, I. Protection of lipid peroxidation and carbonyl formation in proteins by capsaicin in human erythrocytes subjected to oxidative stress. Phytother. Res. 2006, 20, 303–306.
  52. Saad, B.; Zaid, H.; Shanak, S.; Kadan, S. Anti-Diabetes and Anti-Obesity Medicinal Plants and Phytochemicals; Springer: Cham, Switzerland, 2017; pp. 59–93.
  53. Saad, B.; Zaid, H.; Shanak, S.; Kadan, S. Hypoglycemic and antiobesity polyherbal mixtures. In Anti-Diabetes and Anti-Obesity Medicinal Plants and Phytochemicals; Springer: Cham, Switzerland, 2017; pp. 217–253.
  54. Hirai, S.; Takahashi, N.; Goto, T.; Lin, S.; Uemura, T.; Yu, R.; Kawada, T. Functional Food Targeting the Regulation of Obesity-Induced Inflammatory Responses and Pathologies. Mediat. Inflamm. 2010, 2010, 367838.
  55. Isa, Y.; Miyakawa, Y.; Yanagisawa, M.; Goto, T.; Kang, M.S.; Kawada, T.; Morimitsu, Y.; Kubota, K.; Tsuda, Y. 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-α mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2008, 373, 429–434.
  56. Morvaridzadeh, M.; Fazelian, S.; Agah, S.; Khazdouz, M.; Rahimlou, M.; Agh, F.; Potter, E.; Heshmati, S.; Heshmati, J. Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. Cytokine 2020, 135, 155224.
  57. Salem, M.L.; Hossain, M.S. Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus in-fection. Int. J. Immunopharmacol. 2000, 22, 729–740.
  58. Gilani, A.H.; Jabeen, Q.; Khan, M. A review of medicinal uses and pharmacological activities of Nigella sativa. Pak. J. Biol. Sci. 2004, 7, 441–451.
  59. Salem, M.L. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int. Immunopharmacol. 2005, 5, 1749–1770.
  60. Saad, B. Greco-Arab and Islamic Herbal Medicine, A Review. Eur. J. Med. Plants 2014, 4, 249–258.
  61. Hannan, A.; Rahman, M.A.; Sohag, A.; Uddin, J.; Dash, R.; Sikder, M.; Rahman, M.S.; Timalsina, B.; Munni, Y.; Sarker, P.; et al. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients 2021, 13, 1784.
  62. Bordoni, L.; Fedeli, D.; Nasuti, C.; Maggi, F.; Papa, F.; Wabitsch, M.; De Caterina, R.; Gabbianelli, R. Antioxidant and Anti-Inflammatory Properties of Nigella sativa Oil in Human Pre-Adipocytes. Antioxidants 2019, 8, 51.
  63. Montazeri, R.S.; Fatahi, S.; Sohouli, M.H.; Abu-Zaid, A.; Santos, H.O.; Găman, M.A.; Shidfar, F. The effect of Nigella sativa on bi-omarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. J. Food Biochem. 2021, 45, e13625.
  64. Dwita, L.P.; Yati, K.; Gantini, S.N. The Anti-Inflammatory Activity of Nigella sativa Balm Sticks. Sci. Pharm. 2019, 87, 3.
  65. Attia, H.N.; Ibrahim, F.M.; Maklad, Y.A.; Ahmed, K.A.; Ramadan, M.F. Characterization of antiradical and anti-inflammatory activities of some cold pressed oils in carrageenan-induced rat model of acute inflammation. Der Pharma Chem. 2016, 8, 148–158.
  66. Hosseini, B.; Saedisomeolia, A.; Wood, L.G.; Yaseri, M.; Tavasoli, S. Effects of pomegranate extract supplementation on in-flammation in overweight and obese individuals: A randomized controlled clinical trial. Complement. Ther. Clin. Pract. 2016, 22, 44–50.
  67. Laurindo, L.F.; Barbalho, S.M.; Marquess, A.R.; Grecco, A.I.; Goulart, R.D.; Tofano, R.J.; Bishayee, A. Pomegranate (Punica granatum L.) and metabolic syndrome risk factors and outcomes: A systematic review of clinical studies. Nutrients 2022, 14, 1665.
  68. Panth, N.; Manandhar, B.; Paudel, K.R. Anticancer Activity of Punica granatum(Pomegranate): A Review. Phytother. Res. 2017, 31, 568–578.
  69. Shaygannia, E.; Bahmani, M.; Zamanzad, B.; Rafieian-Kopaei, M. A review study on Punica granatum L. J. Evid. Based Complement. Altern. Med. 2016, 21, 221–227.
  70. Giménez-Bastida, J.A.; Ávila-Gálvez, M.Á.; Espín, J.C.; González-Sarrías, A. Giménez-Bastida JA, Ávila-Gálvez MÁ, Espín JC, González-Sarrías A. Evidence for health properties of pomegranate juices and extracts beyond nutrition: A critical systematic review of human studies. Trends Food Sci. Technol. 2021, 114, 410–423.
  71. Wang, P.; Zhang, Q.; Hou, H.; Liu, Z.; Wang, L.; Rasekhmagham, R.; Kord-Varkaneh, H.; Santos, H.O.; Yao, G. The effects of pome-granate supplementation on biomarkers of inflammation and endothelial dysfunction: A meta-analysis and systematic re-view. Complement. Ther. Med. 2020, 49, 102358.
  72. Delpino, F.M.; Figueiredo, L.M.; Caputo, E.L.; Mintem, G.C.; Gigante, D.P. What is the effect of resveratrol on obesity? A systematic review and meta-analysis. Clin. Nutr. ESPEN 2020, 41, 59–67.
  73. Siriwardhana, N.; Kalupahana, N.S.; Cekanovac, M.; LeMieuxa, M.; Greerd, B.; Moustaid-Moussa, N. Modulation of adipose tissue inflammation by bioactive food compounds. J. Nutr. Biochem. 2013, 24, 613–623.
  74. Kim, S.; Jin, Y.; Choi, Y.; Park, T. Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem. Pharmacol 2011, 81, 1343–1351.
  75. Aguirre, L.; Fernández-Quintela, A.; Arias, N.; Portillo, M.P. Resveratrol: Anti-obesity mechanisms of action. Molecules 2014, 19, 18632–18655.
  76. Koushki, M.; Dashatan, N.A.; Meshkani, R. Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clin. Ther. 2018, 40, 1180–1192.e5.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Plant Sciences
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Bashar Saad
View Times: 355
Revisions: 2 times (View History)
Update Date: 11 Nov 2022
Table of Contents
    1000/1000
    Hot Most Recent
    Video Production Service
    Feedback